Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers.

Hyman, David M

Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers. [electronic resource] - Gynecologic oncology Nov 2011 - 196-9 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1095-6859

10.1016/j.ygyno.2011.07.019 doi


Adult
Aged
Disease-Free Survival
Drug Resistance, Neoplasm
Fallopian Tube Neoplasms--drug therapy
Female
Genes, BRCA1
Genes, BRCA2
Humans
Middle Aged
Mutation
Ovarian Neoplasms--drug therapy
Peritoneal Neoplasms--drug therapy
Platinum--therapeutic use
Retrospective Studies
Topoisomerase I Inhibitors--therapeutic use
Topotecan--therapeutic use